Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

ACNP Task Force report on SSRIs and suicidal behavior in youth.

Mann JJ, Emslie G, Baldessarini RJ, Beardslee W, Fawcett JA, Goodwin FK, Leon AC, Meltzer HY, Ryan ND, Shaffer D, Wagner KD.

Neuropsychopharmacology. 2006 Mar;31(3):473-92. Review.

2.

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.

Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ.

Am J Psychiatry. 2007 Sep;164(9):1356-63.

PMID:
17728420
3.

[SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].

Tandt H, Audenaert K, van Heeringen C.

Tijdschr Psychiatr. 2009;51(6):387-93. Review. Dutch.

4.

Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.

Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004851. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD004851.

PMID:
17636776
5.

Antidepressants and suicidal behaviour in unipolar depression.

Yerevanian BI, Koek RJ, Feusner JD, Hwang S, Mintz J.

Acta Psychiatr Scand. 2004 Dec;110(6):452-8.

PMID:
15521830
6.

Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story.

Kutcher S, Gardner DM.

Curr Opin Psychiatry. 2008 Jan;21(1):65-9. doi: 10.1097/YCO.0b013e3282f29853. Review.

PMID:
18281842
7.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
8.

[Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].

Hjalmarsson L, Corcos M, Jeammet P.

Encephale. 2005 May-Jun;31(3):309-16. French.

PMID:
16142045
9.

[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].

Bailly D.

Presse Med. 2006 Oct;35(10 Pt 2):1507-15. Review. French.

PMID:
17028514
10.

Youth suicide trends place SSRIs in spotlight.

[No authors listed]

Behav Healthc Tomorrow. 2004 Feb;13(1):42-5. No abstract available.

PMID:
15002199
11.

Suicide prevention and serotonergic drugs.

Montgomery SA.

Int Clin Psychopharmacol. 1993 Nov;8 Suppl 2:83-5. Review.

PMID:
8201249
12.
13.

[Antidepressants and suicide in adolescents].

Silva M, Sampaio D.

Acta Med Port. 2011 Jul-Aug;24(4):603-12. Epub 2011 Dec 12. Review. Portuguese.

15.

Suicidal risk during controlled clinical investigations of fluvoxamine.

Letizia C, Kapik B, Flanders WD.

J Clin Psychiatry. 1996 Sep;57(9):415-21.

PMID:
9746450
16.
17.

The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.

Weller EB, Tucker S, Weller RA.

Curr Psychiatry Rep. 2005 Apr;7(2):87-90.

PMID:
15802083
18.

Antidepressants and suicidal risk.

Müller-Oerlinghausen B, Berghöfer A.

J Clin Psychiatry. 1999;60 Suppl 2:94-9; discussion 111-6. Review.

19.

Association between Selective Serotonin Reuptake Inhibitor Therapy and Suicidality: Analysis of U.S. Food and Drug Administration Adverse Event Reporting System Data.

Umetsu R, Abe J, Ueda N, Kato Y, Matsui T, Nakayama Y, Kinosada Y, Nakamura M.

Biol Pharm Bull. 2015;38(11):1689-99. doi: 10.1248/bpb.b15-00243.

20.

Use of selective serotonin reuptake inhibitors in children and adolescents.

Wong IC, Besag FM, Santosh PJ, Murray ML.

Drug Saf. 2004;27(13):991-1000. Review.

PMID:
15471506

Supplemental Content

Support Center